Literature DB >> 16675908

The prevalence of endometriosis in women with chronic pelvic pain.

Sun-Wei Guo1, Yuedong Wang.   

Abstract

BACKGROUND: The 2004 American College of Obstetrics and Gynecology clinical management guideline states that the prevalence of endometriosis is approximately 33% in women with chronic pelvic pain (CPP). This estimate came from a review showing that 28% of adult women with CPP were found to have endometriosis. The prevalence of 28% in adult women was arrived based on a compilation of 11 published studies. Yet even within the 11 studies, the reported prevalence of endometriosis varies wildly, ranging from 2 to 74%. Such an astounding variation or heterogeneity raises the question whether it is appropriate to use a single prevalence of endometriosis for all women with CPP.
METHODS: We sought to identify possible sources of heterogeneities in the estimation of prevalence of endometriosis in women with CPP. We included more studies that reported prevalence estimates than the review, and examined the effect of sample size and the year of publication on the heterogeneity.
RESULTS: The year of publication is positively associated with the prevalence estimate, which may indicate an increasing awareness of various appearances of endometriosis, or the prevalence of endometriosis may have increased among women with CPP. An alternative analysis with removal of four studies reporting highest prevalence estimates indicated that sample size is negatively associated with the prevalence estimates while the year of publication became only marginally significant.
CONCLUSIONS: There are identifiable sources of heterogeneity in prevalence estimates, with the year of publication, sample size, and difference in evaluation of CPP being three apparent sources. Having a single prevalence estimate for all women with CPP may be too simplistic at best. The true prevalence is very likely to be higher than 33%.

Entities:  

Mesh:

Year:  2006        PMID: 16675908     DOI: 10.1159/000093019

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  28 in total

Review 1.  Pharmacological treatment of endometriosis: experience with aromatase inhibitors.

Authors:  Simone Ferrero; Pier L Venturini; Nicola Ragni; Giovanni Camerini; Valentino Remorgida
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

2.  Endometriosis-associated pain syndrome: a nurse-led approach.

Authors:  Julia Cambitzi; Maya Nagaratnam
Journal:  Br J Pain       Date:  2013-02

3.  The International Endometriosis Evaluation Program (IEEP Study) - A Systematic Study for Physicians, Researchers and Patients.

Authors:  S Burghaus; T Fehm; P A Fasching; S Blum; S K Renner; F Baier; T Brodkorb; C Fahlbusch; S Findeklee; L Häberle; K Heusinger; T Hildebrandt; J Lermann; O Strahl; G Tchartchian; B Bojahr; A Porn; M Fleisch; S Reicke; T Füger; C-P Hartung; J Hackl; M W Beckmann; S P Renner
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-08       Impact factor: 2.915

Review 4.  Drug delivery for the treatment of endometriosis and uterine fibroids.

Authors:  David R Friend
Journal:  Drug Deliv Transl Res       Date:  2017-12       Impact factor: 4.617

5.  Catastrophizing: a predictor of persistent pain among women with endometriosis at 1 year.

Authors:  C E Martin; E Johnson; M E Wechter; J Leserman; D A Zolnoun
Journal:  Hum Reprod       Date:  2011-09-07       Impact factor: 6.918

6.  Risk factors associated with endometriosis: importance of study population for characterizing disease in the ENDO Study.

Authors:  C Matthew Peterson; Erica B Johnstone; Ahmad O Hammoud; Joseph B Stanford; Michael W Varner; Anne Kennedy; Zhen Chen; Liping Sun; Victor Y Fujimoto; Mary L Hediger; Germaine M Buck Louis
Journal:  Am J Obstet Gynecol       Date:  2013-02-27       Impact factor: 8.661

7.  Thoracic Endometriosis Syndrome: A Veritable Pandora's Box.

Authors:  Sobha S Nair; Jayashree Nayar
Journal:  J Clin Diagn Res       Date:  2016-04-01

8.  Adenomyosis and endometriosis in the California Teachers Study.

Authors:  Claire Templeman; Sarah F Marshall; Giske Ursin; Pamela L Horn-Ross; Christina A Clarke; Mark Allen; Dennis Deapen; Argyrios Ziogas; Peggy Reynolds; Rosemary Cress; Hoda Anton-Culver; Dee West; Ronald K Ross; Leslie Bernstein
Journal:  Fertil Steril       Date:  2007-10-24       Impact factor: 7.329

9.  Thiazolidinediones as therapy for endometriosis: a case series.

Authors:  Molly B Moravek; Elizabeth A Ward; Dan I Lebovic
Journal:  Gynecol Obstet Invest       Date:  2009-07-30       Impact factor: 2.031

Review 10.  Irritable bowel syndrome and chronic pelvic pain: a singular or two different clinical syndrome?

Authors:  Anna Matheis; Ute Martens; Johannes Kruse; Paul Enck
Journal:  World J Gastroenterol       Date:  2007-07-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.